-
DE
L10.3 Pemphigus Foliaceus – ICD-10 Explained
L10.3 is the ICD-10 code for pemphigus foliaceus, a rare autoimmune skin disease characterized by superficial blisters and scaling.
Add as Preferred SourceThings worth knowing about "L10.3"
L10.3 is the ICD-10 code for pemphigus foliaceus, a rare autoimmune skin disease characterized by superficial blisters and scaling.
What is L10.3 (Pemphigus Foliaceus)?
The ICD-10 code L10.3 refers to pemphigus foliaceus, a rare, chronic autoimmune blistering disease of the skin. In this condition, the immune system produces autoantibodies against a specific adhesion protein in the skin called desmoglein 1, which is responsible for holding the upper layers of the skin (epidermis) together. When this protein is attacked, skin cells lose their cohesion in a process called acantholysis, leading to shallow, fragile blisters that rupture easily and leave crusted, scaly wounds. Unlike pemphigus vulgaris (L10.0), pemphigus foliaceus typically does not affect the mucous membranes.
Causes
The exact cause of pemphigus foliaceus is not fully understood, but it is an autoimmune disease in which the body incorrectly produces IgG autoantibodies against desmoglein 1, a protein expressed in the superficial layers of the skin.
- Genetic predisposition: Certain HLA (human leukocyte antigen) types are associated with increased susceptibility.
- Drug-induced pemphigus: Medications such as penicillamine, ACE inhibitors, and certain antibiotics can trigger the condition.
- Environmental factors: An endemic form known as fogo selvagem occurs in rural Brazil and is thought to be triggered by insect bites.
- Association with other autoimmune diseases: Patients with other autoimmune conditions may have a higher risk.
Symptoms
The clinical presentation of pemphigus foliaceus is distinctive:
- Superficial, flaccid blisters: These typically appear first on the face, scalp, chest, and back (seborrhoeic distribution).
- Crusts and erosions: The blisters are fragile and rupture quickly, leaving painful, crusted skin erosions.
- Scaling and redness: Affected areas often appear scaly and erythematous.
- Positive Nikolsky sign: Lateral pressure on apparently normal skin causes the outer skin layer to slide off.
- No mucosal involvement: The mouth, eyes, and genitals are generally not affected.
- Pain and burning sensation: In affected skin areas.
Diagnosis
Diagnosing pemphigus foliaceus (L10.3) involves several steps:
- Clinical examination: Assessment of blister morphology and distribution pattern.
- Skin biopsy: Histology reveals superficial acantholysis within the granular layer of the epidermis.
- Direct immunofluorescence (DIF): Demonstrates IgG deposits between epidermal cells (intercellular pattern).
- Indirect immunofluorescence (IIF) and ELISA: Detects circulating anti-desmoglein 1 antibodies in the blood, which are highly specific for pemphigus foliaceus.
Treatment
Pemphigus foliaceus is a chronic condition that usually requires long-term management aimed at suppressing the abnormal immune response and allowing the skin to heal.
Pharmacological Treatment
- Systemic corticosteroids: Prednisolone is the first-line treatment for rapidly controlling blister formation and inflammation.
- Immunosuppressants: Azathioprine, mycophenolate mofetil, or cyclophosphamide are used as steroid-sparing agents.
- Rituximab: A monoclonal antibody targeting CD20 on B cells, increasingly used in severe or refractory cases and associated with high remission rates.
- Dapsone: May be beneficial in milder cases.
- Topical therapy: Topical corticosteroids and antiseptic wound care help support skin healing.
Prognosis
The course of pemphigus foliaceus is chronic but punctuated by potential remissions. With modern therapies, particularly rituximab, complete remission is achievable for many patients. Regular follow-up with a dermatologist is essential for monitoring disease activity and treatment response.
References
- Hertl M. et al. - Pemphigus. S2k Clinical Guideline, Deutsche Dermatologische Gesellschaft (DDG), 2015.
- Bolognia J.L., Schaffer J.V., Cerroni L. - Dermatology, 4th Edition, Elsevier, 2018.
- Schmidt E., Kasperkiewicz M., Joly P. - Pemphigus. The Lancet, 394(10201): 882-894, 2019.
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Skip product gallery
Subscription available
Floral
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®30 lozenges
Regular price:
22,90 €
Discount
Subscription available
Lactoferrin 60 Capsules
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
60 Capsules
Sale price:
50,00 €
Regular price:
59,90 €
Subscription available
Multivitamin Mineral Complex
Daily basic supply: the complete spectrum of micronutrients
Natural multivitamin complex for the immune system, energy, and central body functions
30 Capsules
Regular price:
29,90 €
Subscription available
Natural Iron
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
30 Capsules
Regular price:
35,90 €